摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Propylisoxazol-3-amine | 55809-37-5

中文名称
——
中文别名
——
英文名称
5-Propylisoxazol-3-amine
英文别名
5-propyl-1,2-oxazol-3-amine
5-Propylisoxazol-3-amine化学式
CAS
55809-37-5
化学式
C6H10N2O
mdl
——
分子量
126.16
InChiKey
ZAXLZOMDJAHIOV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    52
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    5-Propylisoxazol-3-amine光气 生成 3-Isocyanato-5-propylisoxazole
    参考文献:
    名称:
    SUMIMOTO, SINDZABURO;ISIDZUKA, ITIRO;SUGITA, DZITSUO
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Imidazolidinone derivatives
    申请人:ELI LILLY AND COMPANY
    公开号:EP0044185A2
    公开(公告)日:1982-01-20
    Isoxazolylimidazolidinones of the formula I wherein: R' is C1-C6 alkyl; R2 is hydrogen, or taken together with R4 is a double bond; R3 is hydrogen or C,-C6 alkyl; R4 is hydroxy, C1-C6 alkanoyloxy, or taken together with R2 is a double bond; R5 is hydrogen, halo, cyano, nitro, or C1-C6 alkyl; and R6 is hydrogen, C1-C6 alkyl, trifluoromethyl, C1-C3 alkoxy-C1-C6 alkyl, C3-C7 cycloalkyl or C1-C3 alkyl substituted C3-C7 cycloalkyl are useful as herbicides both terrestrial and aquatic.
    式 I 的异噁唑咪唑烷酮 其中 R' 是 C1-C6 烷基; R2是氢,或与R4一起是双键 R3是氢或C,-C6烷基 R4 是羟基、C1-C6 烷氧基,或与 R2 合在一起是双键; R5 是氢、卤代、基、硝基或 C1-C6 烷基;和 R6 是氢、C1-C6 烷基、三甲基、C1-C3 烷氧基-C1-C6 烷基、C3-C7 环烷基或 C1-C3 烷基取代的 C3-C7 环烷基,可用作陆生和除草剂
  • AGENT FOR IMPROVEMENT IN BOUNCE/BODY OF HAIR, AND HAIR COSMETIC
    申请人:Shiseido Company, Limited
    公开号:EP1911750A1
    公开(公告)日:2008-04-16
    A hair resiliency and body improver comprising as the active ingredient thereof one or more types of compounds selected from the group consisting of 2-aminothiazole derivatives represented by the following general formula (1) or 3-aminoisoxazole derivatives represented by the following general formula (2), and pharmaceutically acceptable salts thereof: (wherein, R1, R2, R3, R4, n and m are as defined in the description).
    一种头发弹性和发质改善剂,其活性成分包括一种或多种选自由下通式 (1) 所代表的 2-氨基噻唑生物或自由下通式 (2) 所代表的 3-氨基异恶唑生物组成的组的化合物及其药学上可接受的盐类: (其中,R1、R2、R3、R4、n 和 m 如说明中所定义)。
  • Hair resiliency / body improver and hair cosmetic
    申请人:Shiseido Company, Limited
    公开号:EP2484342A1
    公开(公告)日:2012-08-08
    A hair resiliency and body improver comprising as the active ingredient thereof one or more types of compounds selected from the group consisting of 2-aminothiazole derivatives represented by the following general formula (1) or 3-aminoisoxazole derivatives represented by the following general formula (2), and pharmaceutically acceptable salts thereof: (wherein, R1, R2, R3, R4, n and m are as defined in the description).
    一种头发弹性和发质改善剂,其活性成分包括一种或多种选自由下通式 (1) 所代表的 2-氨基噻唑生物或自由下通式 (2) 所代表的 3-氨基异恶唑生物组成的组的化合物及其药学上可接受的盐类: (其中,R1、R2、R3、R4、n 和 m 如说明中所定义)。
  • Bisphosphonic acid derivatives and medicines containing the same
    申请人:YAMANOUCHI PHARMACEUTICAL CO., LTD.
    公开号:EP0282320B1
    公开(公告)日:1991-12-11
  • Hair resiliency/body improver and hair cosmetic
    申请人:Suetsugu Masaru
    公开号:US20090233975A1
    公开(公告)日:2009-09-17
    A hair resiliency and body improver comprising as the active ingredient thereof one or more types of compounds selected from the group consisting of 2-aminothiazole derivatives represented by the following general formula (1) or 3-aminoisoxazole derivatives represented by the following general formula (2), and pharmaceutically acceptable salts thereof: (wherein, R 1 , R 2 , R 3 , R 4 , n and m are as defined in the description).
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)